Cardiac automaticity is controlled by G protein-coupled receptors, such as adrenergic, muscarinic, and adenosine receptors. The strength and duration of G protein signaling is attenuated by regulator of G protein signaling (RGS) proteins acting as GTPase-activating proteins for G␣ subunits; however, little is known about the role of endogenous RGS proteins in cardiac function. We created point mutations in G␣ subunits that disrupt G␣-RGS binding and introduced them into embryonic stem (ES) cells by homologous recombination. Spontaneously contacting cardiocytes derived from the ES cells were used to evaluate the role of endogenous RGS proteins in chronotropic regulation. The RGS-insensitive G␣ o G184S homozygous knock-in (G␣ o GS/GS) cells demonstrated enhanced adenosine A 1 and muscarinic M 2 receptor-mediated bradycardic responses. In contrast, G␣ i2 GS/GS cells showed enhanced responses to M 2 but not A 1 receptors. Similarly M 2 but not A 1 bradycardic responses were dramatically enhanced in G␣ i2 GS/GS mice. Blocking G protein-coupled inward rectifying K ϩ (GIRK) channels largely abolished the mutation-induced enhancement of the M 2 receptor-mediated response but had a minimal effect on A 1 responses. The G␣ s -dependent stimulation of beating rate by the ␤ 2 adrenergic receptor agonist procaterol was significantly attenuated in G␣ o GS/GS and nearly abolished in G␣ i2 GS/GS cells because of enhanced signaling via a pertussis toxin sensitive mechanism. Thus, endogenous RGS proteins potently reduce the actions of G␣ i/o -linked receptors on cardiac automaticity. Furthermore, M 2 and A 1 receptors differentially use G␣ i2 and G␣ o and associated downstream effectors. Thus, alterations in RGS function may play a role in pathophysiological processes and RGS proteins could represent novel cardiovascular therapeutic targets. (Circ Res. 2006;98:659-666.) 
G protein-coupled receptors (GPCRs) control many cardiovascular functions, such as automaticity and contractility and cell growth and survival. 1 Cardiac ion channels are key effectors, including activation of the G protein-coupled inward rectifying potassium (GIRK) channels by ␤␥ subunits released from G␣ i and inhibition of I f and I Ca,L by G␣ o , whereas I Ca,L is also regulated by G␣ i and nitric oxide. [2] [3] [4] [5] GIRK channels contribute approximately 50% of the in vivo bradycardic response to vagal stimulation, 6 but the relative contribution of different G␣ subunits to in vivo cardiac automaticity is less clear.
The recently identified regulators of G protein signaling (RGS) proteins reduce the strength and duration of G protein signaling by acting as GTPase accelerating proteins (GAPs) through their conserved RGS domain. 7 Mammalian myocardium expresses more than 10 different RGS proteins (2, 3, 4, 5, 6, 7, 12, 14, 16, and 19) , which have GAP activity toward G␣ i/o and G␣ q/11 family G proteins. 8 Indeed, the first reported mammalian RGS effect was the rapid deactivation of GIRK currents in atrium 9 and RGS proteins also contribute to agonist-, calcium-, and voltage-dependent relaxation of GIRK currents. 10 -12 These results suggest an important role for RGS proteins in sinoatrial (SA) node function and potentially in atrial arrhythmias. More recently, hypertension in the RGS2 knockout mouse illustrates the importance of RGS proteins in cardiovascular regulation. 13, 14 Little is known about the role of endogenous cardiac RGS proteins, but they are dynamically regulated in a variety of pathophysiological conditions, including cardiac hypertrophy 15 and heart failure. 16, 17 It was proposed recently that RGS proteins represent potential new therapeutic targets for cardiovascular diseases. 18 However, it has been difficult to ascertain the full physiological role of endogenous RGS proteins in vivo in part because of their functional redundancy. Thus, we used RGS-insensitive (RGSi) mutant G␣ subunits, which contain a G184S point mutation in their switch I region that prevents binding of RGS proteins and the subsequent G␣ deactivation. 19 These G␣ mutations do not affect the intrinsic GTPase activity, G␤␥ subunit binding, receptor stimulation, or the ability to signal to downstream effectors. 20 Expression of these RGSi G␣ subunits significantly enhances G␣ i/o -mediated signaling. 21, 22 However, overexpression of RGSi G␣ mutants and the use of pertussis toxin (PTX)-insensitive mutants complicate data interpretation. Therefore, we introduced RGSi mutants of G␣ o and G␣ i2 into embryonic stem (ES) cells by homologous recombination so that expression of the mutant G␣ is under the control of their endogenous promoters (G␣RGSi knock-ins), thus allowing us to assess the functional contribution of all RGS proteins involved in regulation of that specific G␣ subunit.
Two questions have been addressed in this study. First, do endogenous RGS proteins modulate cardiac signaling by G␣ o and G␣ i2 ? Second, is there specificity in the signaling pathways from receptors to G protein subunits and their downstream effectors? We show that A 1 adenosine, M 2 muscarinic, and ␤ 2 -adrenergic chronotropic signals are all strongly modulated by endogenous RGS proteins. Furthermore, A 1 receptor (A 1 R) preferentially couples to G␣ o and leads to a largely GIRK-independent bradycardic response. In contrast, G␣ i2 plays a major role in the M 2 muscarinic response mediated through GIRK channel activation. Also, G␣ i2 couples better to ␤ 2 adrenergic receptor (␤ 2 AR) than G␣ o does. Thus inhibiting RGS proteins that reduce G␣ o or G␣ i2 function may permit selective enhancement of adenosine or muscarinic, ␤ 2 -negative chronotropic, or cardioprotective actions.
Materials and Methods

Generation of RGS-Insensitive ES Cells and Mice and In Vitro Differentiation to Cardiocytes
We generated heterozygous and homozygous G␣ o RGSi 20 and G␣ i2 RGSi knock-in ES cell lines and created G␣ i2 RGSi knock-in mice (see the online data supplement available at http://circres. ahajournals.org). Wild-type cells and mice are designated ϩ/ϩ, heterozygote G␣ o G184S are G␣ o ϩ/GS, and homozygous G␣ o GS/GS with similar designations of G␣ i2 ϩ/GS and G␣ i2 GS/GS. Two clones each from 2 independently derived knock-in cell lines were examined for each G␣ to ensure consistency of the phenotype. ES-derived cardiocytes (ESDC) were differentiated by a hanging drop protocol 20 modified from Hescheler et al. 23 These cells have been described as having an "atrial-nodal" character and their differentiation was confirmed by mRNA expression of cardiacspecific genes, such as ␣and ␤-myosin heavy chain, MLC2a, MLC2v, atrial natriuretic factor, and the cardiac transcriptional factors GATA4 and Nkx2.5 (data not shown). G␣ i2 ϩ/GS mice show minimal overt phenotypic changes, whereas G␣ i2 GS/GS have reduced body weights and show reduced viability.
Beating Rate Measurements
ESDC beating rate measurements were performed 21 to 25 days after withdrawal of leukemia inhibitory factor. Basal beating rate was recorded after at least 30 minutes at room temperature, then beating rates were counted for 30 seconds, 5 minutes after each drug administration. 20 Isoproterenol (Iso), procaterol, R-PIA, carbachol, CPX (8-cyclopentyl, 1,3-dipropylxanthine), PTX, and ICI 118,551 were obtained from Sigma. rTertiapinQ was obtained from Alomone Labs.
Statistical Analysis
Data are reported as meanϮSEM. Beating rates are compared by 2-way ANOVA with Bonferroni post test (GraphPad Prism 4.0). Nonlinear least squares analysis with global fitting (online data supplement) and F test was used to fit and compare dose-response data, with PϽ0.05 considered significant.
Results
Enhanced Adenosine and Muscarinic Bradycardic Responses in G␣ o RGSi Mutant Cells
In ESDC, adrenergic, cholinergic, and adenosine signaling pathways are functionally intact and G␣ subunit expression is normal (Figures I and II in the online data supplement). The selective A 1 R agonist R(-)N6-(2-phenylisopropyl)-adenosine (R-PIA) was significantly more potent in the G␣ o RGSi cells with 4-and 6.4-fold reductions in IC 50 for heterozygous (G␣ o ϩ/GS) and homozygous (G␣ o GS/GS) cells, respectively ( Figure 1A) . Similar results were seen in 2 clones of heterozygous and homozygous cells (not shown). Moreover, Figure 1 . Negative chronotropic responses are enhanced in G␣ RGSi mutant cells. Iso-stimulated (50 nmol/L) beating rates were measured with increasing concentrations of the adenosine A 1 agonist, R-PIA (A and C), or the muscarinic M 2 agonist carbachol (Carb) (B and D). Experiments were conducted in parallel with beating foci from wildtype ϩ/ϩ (solid line), G␣ o ϩ/GS (dashed line), and G␣ o/i2 GS/GS (dotted line) cell lines on the same day after differentiation. Beating colonies of ϩ/GS and GS/GS knock-in cells were derived from 2 independent clones, which demonstrated similar results, so the combined results are shown. A preliminary version of the data in A has been reported previously. 20 Data were normalized to the total beating rate after Iso stimulation. **PϽ0.001. maximal inhibition by R-PIA was significantly enhanced in both knock-in cell lines (ϩ/GS, 88Ϯ3%; GS/GS, 82Ϯ3%) compared with wild-type cells (68Ϯ3%) (PϽ0.001). The increase in agonist sensitivity in heterozygous G␣ o ϩ/GS cells is consistent with the expected semidominant phenotype because loss of RGS GAP activity at even half of the G␣ subunits should lead to a substantial increase in active G protein. G␣ o GS/GS cells also showed enhanced sensitivity to the M 2 receptor (M 2 R) agonist carbachol (7-fold decrease in IC 50 ) without a significant difference in maximal inhibition ( Figure 1B ).
Enhanced Muscarinic but Not Adenosine Bradycardic Responses in Cells Expressing G␣ i2 RGSi Mutant G Protein
G␣ i2 is the predominant isoform of inhibitory G proteins in mammalian myocardium and plays a largely parallel role with G␣ o in regulation of cardiac automaticity. We obtained targeted G␣ i2 RGSi ES cells and Western blotting showed that the mutation does not alter the expression of G␣ i2 in either ES cells or in heart from the G␣ i2 mutant mice ( Figure IC and ID in the online data supplement). Interestingly, G␣ i2 appears to play less of a role in adenosine-mediated bradycardia than does G␣ o , with only a nonsignificant 2.5-fold reduction in the R-PIA IC 50 for G␣ i2 GS/GS cells compared with the 6.4-fold decrease for G␣ o GS/GS cells. Plus, there was no significant difference in maximal stimulation ( Figure 1C ). In contrast, G␣ i2 GS/GS cells showed dramatically enhanced M 2 R responses with 5.4-fold reduction in IC 50 and 71% increase in maximal inhibition (72% versus 42%) when compared with ϩ/ϩ cells ( Figure 1D ), indicating that G␣ i2 preferentially couples to M 2 R versus A 1 R.
Pacemaker I f and GIRK Currents Regulate Beating Rate in ESDC
To begin to address the ionic mechanisms of these receptor signals, we examined the role of I f and GIRK in ESDC automaticity. The pacemaker current, I f , has been shown to mediate ␤-adrenergic stimulation and to contribute to cholinergic inhibition of heart rate 24 and is a major mechanism for pacemaker activity. Deletion of the gene underlying I f , HCN4, results in severe bradycardia and chronotropic incompetence. 25 Similarly in ESDC, the selective I f blocker ZD7288 nearly inhibits spontaneous beating by Ϸ60% and virtually eliminates ␤-adrenergic stimulation (Figure 2A ). Thus, it was difficult to assess the effects of inhibitory agonists on this channel as most of our other functional studies were in the presence of Iso.
In contrast, the GIRK blocker rTertiapinQ at 100 nmol/L did not affect basal or Iso-stimulated beating but decreased the carbachol-mediated reduction of Iso-stimulated beating rate from 40Ϯ3% to 22Ϯ2% ( Figure 2B ). This result is consistent with the 50% contribution of GIRK channel in negative chronotropic response mediated by M 2 R reported in GIRK knockout animals. 6 Interestingly, however, inhibition of beating by R-PIA was barely affected by rTertiapinQ (43Ϯ5% versus 36Ϯ6%), indicating that GIRK channel activation contributes minimally to regulation of automaticity by the A 1 R despite its ability to activate GIRK currents. 26 Although we cannot completely rule out a role for GIRK currents, it is apparent that the M 2 and A 1 responses differ substantially in their dependence on GIRK currents.
Enhanced Bradycardia by M 2 R but Not A 1 R in G␣ o/i2 RGSi Cells Is Primarily Mediated by Enhanced of GIRK Channel Activation
In presence of the specific GIRK channel blocker rTertiap-inQ, carbachol produced a much smaller bradycardic response, but, more importantly, the difference in IC 50 and maximal inhibition between ϩ/ϩ and G␣ i2 GS/GS cells was largely abolished ( Figure 3A ). Thus, augmented GIRK channel activation caused by lack of RGS regulation is largely responsible for the enhanced bradycardic response on M 2 R activation, whereas other pathways are less RGS regulated. Interestingly, the IC 50 shift for carbachol with the G␣ o GS/GS cells was also reduced (2.3-fold versus 6.8-fold) with rTer-tiapinQ (Table) . On the other hand, rTertiapinQ has a minimal effect on R-PIA-induced inhibition of beating rate. In the presence of the GIRK blocker, G␣ o GS/GS cells still show a 5.4-fold lower IC 50 for R-PIA than do ϩ/ϩ cells. This suggests that endogenous RGS proteins regulate pathways signaling to other downstream effectors such as I Ca,L and I f rather than GIRK channel on activation of G␣ o by A 1 R.
Diminished Positive Chronotropic Response in G␣ o/i2 RGSi Mutant Cells Following ␤ 2 AR Activation
␤ARs play a pivotal role in the control of cardiovascular function by mediating the actions of sympathetic nervous system activation and circulating catecholamines. Although the ␤ 1 AR is the predominant subtype in the hearts of many species, both ␤ 1 and ␤ 2 subtypes can increase cardiac automaticity and contractility. 27 Although most of actions of the ␤ 2 AR are mediated through G␣ s proteins and protein kinase A, ␤ 2 AR can also couple to inhibitory G proteins, which have been suggested to account for their apparent cardioprotective action. 28, 29 Because endogenous RGS proteins act on G␣ i/o family G proteins but not on G␣ s , it is plausible to hypothesize that RGS proteins could modulate the actions of the ␤ 2 AR, including chronotropic regulation.
Procaterol, a selective ␤ 2 AR agonist, 30 stimulates the ESDC beating rate. This tachycardia is mediated by ␤ 2 ARs because it is blocked by 200 nmol/L ICI 118,551, a ␤ 2 AR selective antagonist, and not by the selective ␤ 1 AR antagonist CGP 20712A, which inhibits Iso simulation ( Figure III in the online data supplement). The EC 50 for procaterol was not different between ϩ/ϩ cells and 2 clones of G␣ o GS/GS cells ( Figure 4A ). However, maximal stimulation by procaterol is significantly attenuated in 2 independent G␣ o GS/GS cells lines (dashed and dotted lines, 131% and 135%, respectively) compared with ϩ/ϩ cells (solid line, 178%). In contrast, Iso-stimulated beating rates did not differ among the 3 cell types. This suggests that endogenous RGS proteins control ␤ 2 AR effects on beating rate by reducing the action of G␣ o . This is intriguing because ␤ 2 AR coupling to G␣ o has not been reported previously. PTX was used to test whether the difference in procaterol response was caused by overactive inhibitory G proteins. The difference between G␣ o GS/GS and wild-type cells was abolished by PTX treatment ( Figure IV in the online data supplement), confirming that G␣ i/o family coupling of the ␤ 2 AR is under tonic control by endogenous RGS proteins.
An even more striking difference was seen in G␣ i2 GS/GS mutant cells. A slight negative chronotropic response to procaterol occurred at low doses but was overcome at higher doses. Thus endogenous RGS proteins dramatically regulate ␤ 2 AR chronotropy such that the G␣ i2 -mediated suppression overcomes G␣ s -mediated stimulation if the GAP activity of RGS is blocked. Similar to the striking left shifts of the carbachol and R-PIA dose-response curves in RGSi cells, the effect of procaterol on G␣ i2 -mediated inhibition occurs at much lower concentrations, whereas G␣ s effects do not shift. Thus endogenous RGS proteins strongly suppress G␣ i2 effects in the heart.
M 2 R-Mediated Response Is Selectively Enhanced in G␣ i2 GS/GS Mice
Because ES cell studies may not fully replicate results in vivo, we developed G␣ i2 RGSi knock-in mice to assess the The IC 50 and percentage of inhibition were obtained by curve fitting to sigmoidal dose-response curves using GraphPad Prism 4. Statistical significance was determined using global fitting analysis (see the online data supplement), comparing wild-type ϩ/ϩ with mutant RGSi cells. *PϽ0.05, **PϽ0.001. ND indicates not determined.
Summary of Agonist Sensitivity in G␣ o GS/GS or G␣ i2 GS/GS Versus ؉/؉ Cells and in the Presence of rTertiapinQ
role of RGS proteins in the M 2 receptor (M 2 R)/A 1 R specificity of chronotropic regulation in the intact animal. Heart rate was continuously monitored in unconstrained mice by telemetry. Baseline heart rates in the G␣ i2 GS/GS mice were slightly higher than wild type (588Ϯ11 versus 571Ϯ8 bpm). Administration of the A 1 R agonist 2-chloro-N 6 -cyclopentyladenosine (CCPA, 0.1 mg/kg, IP) led to a significant reduction in heart rate in both ϩ/ϩ and G␣ i2 GS/GS mice but showed no difference between genotypes.
In contrast, IP injection of the standard dose of 0.5 mg/kg carbachol resulted in profound bradycardia and death in 1 homozygous G␣ i2 GS/GS mouse, whereas the wild-type mice showed a 293Ϯ44 bpm decrease (nϭ2). A much smaller dose of 0.2 mg/kg carbachol ( Figure 5 ) induced very little effect in ϩ/ϩ animals but produced a dramatic reduction in heart rate of G␣ i2 GS/GS mice (Ϫ48 versus Ϫ295 bpm, PϽ0.001). This confirmation of the muscarinic selectivity of the G␣ i2 RGSi effect strongly supports the validity of our ESDC model of chronotropic regulation ( Figure 6 ) and also illustrates, in vivo, the strength and specificity of RGS effects in modulating GPCR signals despite similar signaling pathways.
Discussion
We demonstrate that endogenous RGS proteins potently regulate chronotropic responses to muscarinic, adenosine, and ␤ 2 adrenergic receptors. Furthermore, the RGSinsensitive G␣ subunits reveal dramatic differences in the signaling pathways and channel mechanisms used in cardiac chronotropic control by A 1 adenosine and M 2 muscarinic receptors. The remarkable, and even lethal, increase in carbachol responsiveness in vivo illustrates the potential importance of RGS protein modulation in both pathological and pharmacological situations.
Role of RGS Proteins in the Heart
Most information on mammalian RGS proteins derives from transfection experiments but overexpressed proteins may behave differently from their endogenous counterpart both in cellular localization and relative abundance to other family members. 31 In contrast, we used homologous recombination in ES cells in which the mutant protein is under the control of its native promoter and expressed at normal levels. More importantly, the RGSiG␣ subunits reveal the contribution from all endogenous RGS proteins, avoiding complications from redundancy caused by multiple RGS proteins. Thus, we provide the first demonstration of a role of endogenous RGS proteins in the normal physiological regulation of cardiac function.
G Protein Pathways Used by A 1 R and M 2 R
The enhanced activation of G␣ o and G␣ i2 subunits by incorporation of the RGSi mutation reveals the broad coupling of muscarinic M 2 R to G␣ o and G␣ i2 but preferential coupling of adenosine A 1 receptor to G␣ o . This is despite the quite similar actions of A 1 R and M 2 R in regulating chronotropy and inotropy. The physiological significance of the preferential M 2 R-G␣ i2 coupling is strongly supported by our in vivo data, whereas G␣ i2 -RGSi mice had unchanged responses after CCPA administration.
Previous data have suggested some G␣ i and G␣ o selectivity of these receptors, but the degree to which this is functionally relevant has not been clear. In human myocardium, M 2 R but not A 1 R is able to maximally activate [ 35 S]GTP␥S binding to G␣ subunits. 32 In cardiac membranes, M 2 R coimmunoprecipitated with both G␣ o and G␣ i proteins, 33 whereas purified G␣ o was found to efficiently reconstitute A 1 R. 34 Coimmunoprecipitation of activated A 1 R with G␣ o and G␣ i3 but not G␣ i2 was also seen in rat ventricle. 35 There may, however, be factors beyond just G protein that determine RGS control of the functional responses to M 2 and A 1 receptors. Unlike the M 2 R, which is dynamically targeted to caveolae on agonist binding, 36 A 1 R localizes in caveolae in unstimulated ventricular myocytes and translocates out after receptor occupancy. 37 It is possible that the more pronounced effect of the GIRK channel blocker on the enhanced M 2 responses in the G␣ o GS/GS cells versus the A 1 response in the same cells (Table) may be related to localization rather than just G protein specificity. Indeed, we predicted 38 that RGS proteins may enhance specificity of G protein signaling by a "kinetic scaffolding" mechanism that limits the diffusion of active G␣ and ␤␥ subunits to very short (nanometer) distances from the receptor. Thus, the modest but significant difference in maximal stimulation by R-PIA and 7-fold EC 50 shift for carbachol between ϩ/ϩ and G␣ o GS/GS cells that were lost in presence of rTertiapinQ suggests potential GIRK coupling by the mutant G␣ o .
Role of GIRK Currents in A 1 R-and M 2 R-Mediated Negative Chronotropy
The contribution of GIRK currents to M 2 R-versus A 1 Rmediated bradycardia appears to be quite different. Despite the ability of both M 2 R and A 1 R to activate GIRK currents, 26 the A 1 R responses in ESDC are largely untouched by the GIRK blocker rTertiapinQ, whereas M 2 R-induced negative chronotropy is reduced by 45% ( Figure 2B ). Furthermore, rTertiapinQ almost completely abolished the increase in maximal inhibition and reduction in IC 50 to carbachol in G␣ i2 GS/GS mutant. This suggests that M 2 -G␣ i2 -GIRK is a primary pathway mediating the M 2 R chronotropic response, and it is tightly regulated by endogenous RGS proteins.
In contrast, the enhanced sensitivity to R-PIA in G␣ o GS/GS mutant cells is largely maintained in presence of rTertiapinQ, indicating minimal contribution of GIRK activation in A 1 R-mediated negative chronotropy. Given that A 1 R preferentially couple to G␣ o , the minimal role of GIRK is perhaps not surprising because specificity of G␣ i2 over G␣ o in activating GIRK currents is well established. Sowell et al 2 demonstrated that the expression of G␣ i2 and G␣ i3 is required for normal agonist-dependent activation of GIRK current, whereas G␣ o knockout cells show normal GIRK responses but altered I Ca,L regulation. 3 Furthermore, the A 1 R has an 11-fold lower EC 50 for suppression of Iso-stimulated I Ca,L compared with its action on GIRK current. 39 Altogether, these prior data suggest that A 1 R ought to use a non-GIRK pathway (eg, I Ca,L ) in mediating its bradycardic effects. Our results illustrate in vitro and in vivo the dramatic difference in signaling pathways (G␣ i2 -GIRK and G␣ o -non-GIRK) in negative chronotropic regulation by M 2 R and A 1 R, respectively.
There is a discrepancy, however, between our conclusion and that of Wickman et al 6 where disruption of GIRK4 in vivo results in a 50% loss of the A 1 R-mediated negative chronotropic response, an effect similar to that for vagal bradycardia. 6 They used a relatively high dose of CCPA (0.3 mg/kg), which may lead to more "spill-over" of A 1 responses to a G␣ i2 pathway or to high degrees of G␣ o activation that could lead to GIRK coupling. Previous studies showed that the A 1 R in rat myocytes can activate only a fraction of the magnitude of GIRK current that is activated via the M 2 R. 40, 41 A 1 R density was suggested to limit responsiveness because the receptor overexpression does enhance GIRK current Figure 6 . Proposed roles of G␣ and RGS proteins in chronotropic regulation of the heart. Some GPCRs can couple to multiple isoforms of G proteins from same family (ie, M 2 R), and some couple to G proteins from different families exerting counteracting effects (ie, ␤ 2 AR). Vagal stimulation activates M 2 R, which couples well to both G␣ i2 and G␣ o . The ␤␥ subunits from G␣ i2 but not G␣ o directly activate GIRK currents, leading to negative chronotropic effects. This pathway is highly regulated by endogenous RGS proteins. In contrast, ␤␥ released from G␣ o does not normally activate GIRK currents, but, in the absence of RGS control (G␣ o GS/GS), there is modest activation of GIRK. Adenosine A 1 Rs preferentially couple to G␣ o rather than G␣ i2 to inhibit heart rate, but they only minimally use GIRK currents for this response rather I Ca,L or I f are likely effectors. Also, ␤ 2 AR can couple to multiple isoforms in the G␣ i family with preference for G␣ i2 over G␣ o . Furthermore, these effects are normally kept in check by endogenous RGS proteins. Thus, RGS proteins play a central role in chronotropic regulation and are likely to modulate cardioprotective functions of G␣ i/o signaling.
activation. 41 It is also possible that the discrepancy between our results and those Wickman et al, could derive from the ESDC versus animal models, but we also see a dramatic difference between carbachol and CCPA in the G␣ i2 RGSi mice. Interestingly, the effect of the G␣ i2 RGSi on vagal bradycardia induced by methoxamine was significant but much less than with direct activation by carbachol (data not shown); therefore, perhaps CNS control of vagal reflexes (which are involved for methoxamine but less so for carbachol responses) is altered in GIRK4 knockout.
This strong regulation by endogenous RGS proteins on GIRK currents suggests potential involvement in pathophysiology of arrhythmias. GIRK4 knockout mice and mice with reduced expression of membrane-associated G protein ␤␥ subunits exhibited significantly reduced beat-to-beat fluctuation in heart rate and had a reduced propensity for atrial fibrillation. 42, 43 Therefore, loss of RGS function, either by G␣ mutations or loss of individual RGS proteins, might be expected to increase GIRK activation and enhanced propensity for atrial fibrillation. Furthermore, G␣ i2 plays a clear role in ␤ 2 AR signaling and G␣ i2 enhances survival in the face of ␤ 2 AR overexpression, so inhibiting cardiac RGS may provide a novel approach to cardioprotection. The blunted maximal stimulation by ␤ 2 AR in G␣ o GS/GS mutants is the first convincing evidence for ␤ 2 AR-G␣ o coupling. Taken together, these data suggest that ␤ 2 AR-mediated action may also involve multiple G␣ i/o subunits.
In summary, we show that endogenous RGS proteins potently modulate the G␣ i/o -mediated regulation of cardiac automaticity, leading to enhanced bradycardic responses on A 1 R and M 2 R activation. Moreover, there is clear specificity between G␣ i2 and G␣ o in this chronotropic control in vivo and in vitro. A 1 R-mediated negative chronotropic actions are through preferential coupling to G␣ o and minimally involve GIRK currents, whereas M 2 R coupling uses both G␣ i2 and G␣ o and their appropriate effectors. Thus, the G␣RGSi knock-in mice represent a valuable model for studying the both G␣ subunit roles in signaling by different receptors as well as in understanding the function of endogenous RGS proteins in vivo. Our results suggest that RGS inhibitors targeting the G␣ o -selective RGS proteins, such as RGS6, should potentiate adenosine responses more than M 2 effects. The striking enhancement of carbachol-induced bradycardia with the RGSi G␣ subunits shows that pathophysiological alterations in RGS control of G␣ i/o could contribute to sinus node dysfunction and/or atrial arrhythmias. Furthermore, ␤ 2 AR action via both G␣ i2 and G␣ o subunits is under tonic suppression by endogenous RGS proteins. Future studies to determine whether cardioprotective actions of ␤ 2 AR and other G␣ i/o -coupled receptors can be enhanced by blocking RGS proteins should be of great interest, as should be identification of the individual RGS protein(s) responsible for these regulatory processes.
